Insight Molecular Diagnostics Inc. (0KCC)
LSE
Closed
Oct 9, 2026
Day's Range
3.2552 wk Range
2.45Overview - 0KCC - Insight Molecular Diagnostics Inc.
Key Statistics
Valuation
Enterprise Value
95.04M
EV / EBITDA
‪-2.75‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-3,815.06%‬
Return on Assets
‪-57.82%‬
Ownership
Shares Outstanding
40.66M
Float
9.97M
Held by Insiders
‪20.99%‬
Held by Institutions
‪56.42%‬
Price stats
Beta
‪1.80‬
50-Day Avg
‪1.77‬
200-Day Avg
‪1.77‬
Market Cap - 0KCC - Insight Molecular Diagnostics Inc.
Peers - 0KCC - Insight Molecular Diagnostics Inc.
Peer Comparison
Compared with companies in Diagnostics & Research listed on LSE.
- 0KCCLSEInsight Molecular Diagnostics Inc.133.78MMarket Cap-17.99%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- 0R0HLSEThermo Fisher Scientific Inc.270.26BMarket Cap+31.11%52-week change0.35P/E (Trailing)‪15.03%‬Profit Margin
- MTOLSEMitie Group plc260.80BMarket Cap+33.01%52-week change34.77P/E (Trailing)‪1.47%‬Profit Margin
- SHCLSEShaftesbury Capital PLC251.54BMarket Cap-2.55%52-week change6.63P/E (Trailing)‪156.72%‬Profit Margin
- 0R2BLSEDanaher Corp.156.84BMarket Cap+16.73%52-week change0.26P/E (Trailing)‪15.94%‬Profit Margin
- 0JDMLSEIQVIA Holdings Inc.54.85BMarket Cap+34.03%52-week change0.49P/E (Trailing)‪8.09%‬Profit Margin
- 0HAVLSEAgilent Technologies Inc.54.73BMarket Cap+28.24%52-week change0.41P/E (Trailing)‪19.53%‬Profit Margin
Profile Summary - 0KCC - Insight Molecular Diagnostics Inc.
About
Insight Molecular Diagnostics Inc. is a molecular diagnostics company focused on precision testing for transplantation and oncology. The company develops and commercializes laboratory-developed, kitted research-use, and clinical diagnostic tests that help clinicians assess organ rejection, monitor therapeutic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
